These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17051236)

  • 1. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/insulin resistance?
    Sarafidis PA; Bakris GL
    J Hum Hypertens; 2007 Jan; 21(1):12-9. PubMed ID: 17051236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of insulin, glucagon, lactate, and nonesterified fatty acids to glucose in visceral obesity with and without NIDDM: relationship to hypertension.
    Iannello S; Campione R; Belfiore F
    Mol Genet Metab; 1998 Mar; 63(3):214-23. PubMed ID: 9608544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects.
    Iannello S; Milazzo P; Belfiore F
    Obes Rev; 2007 May; 8(3):231-51. PubMed ID: 17444965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute elevation of plasma non-esterified fatty acids increases pulse wave velocity and induces peripheral vasodilation in humans in vivo.
    Riksen NP; Bosselaar M; Bakker SJ; Heine RJ; Rongen GA; Tack CJ; Smits P
    Clin Sci (Lond); 2007 Jul; 113(1):33-40. PubMed ID: 17309447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes.
    Cnop M
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):348-52. PubMed ID: 18481955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central sympathetic outflow to skeletal muscle: the major link between non-esterified fatty acids and elevated blood pressure?
    Schlaich M
    Clin Sci (Lond); 2009 Oct; 118(1):43-5. PubMed ID: 19594440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.
    Jonk AM; Houben AJ; de Jongh RT; Serné EH; Schaper NC; Stehouwer CD
    Physiology (Bethesda); 2007 Aug; 22():252-60. PubMed ID: 17699878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome.
    Makino S; Fujiwara M; Suzukawa K; Handa H; Fujie T; Ohtaka Y; Komatsu Y; Aoki Y; Maruyama H; Terada Y; Hashimoto K; Sugimoto T
    Horm Metab Res; 2009 Mar; 41(3):221-6. PubMed ID: 19003725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydropyridine calcium channel blockers inhibit non-esterified-fatty-acid-induced endothelial and rheological dysfunction.
    Yasu T; Kobayashi M; Mutoh A; Yamakawa K; Momomura S; Ueda S
    Clin Sci (Lond); 2013 Sep; 125(5):247-55. PubMed ID: 23535137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha -238G>A genotype alters postprandial plasma levels of free fatty acids in obese individuals with type 2 diabetes mellitus.
    Fontaine-Bisson B; Wolever TM; Chiasson JL; Rabasa-Lhoret R; Maheux P; Josse RG; Leiter LA; Rodger NW; Ryan EA; El-Sohemy A
    Metabolism; 2007 May; 56(5):649-55. PubMed ID: 17445540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of aldosterone with obesity-related hypertension and the metabolic syndrome.
    Vogt B; Bochud M; Burnier M
    Semin Nephrol; 2007 Sep; 27(5):529-37. PubMed ID: 17868790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertension and other complications in human obesity.
    Björntorp P
    J Clin Hypertens; 1986 Jun; 2(2):163-5. PubMed ID: 3531415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity increases free thyroxine proportionally to nonesterified fatty acid concentrations in adult neutered female cats.
    Ferguson DC; Caffall Z; Hoenig M
    J Endocrinol; 2007 Aug; 194(2):267-73. PubMed ID: 17641276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduced nocturnal systolic blood pressure dip in obese children].
    Ruiz Pons M; García Nieto V; García MG; García Mérida M; Valenzuela Hdez C; Aguirre-Jaime A
    Nefrologia; 2008; 28(5):517-24. PubMed ID: 18816210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of coronary disease].
    Dietze GJ; van Erckelens F; Bunse M; Jung WI
    Z Kardiol; 2000; 89 Suppl 7():7-10. PubMed ID: 11098553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.